1-215650744-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_206933.4(USH2A):c.14191G>A(p.Gly4731Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000165 in 1,613,634 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G4731W) has been classified as Uncertain significance.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.14191G>A | p.Gly4731Arg | missense_variant | 65/72 | ENST00000307340.8 | NP_996816.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.14191G>A | p.Gly4731Arg | missense_variant | 65/72 | 1 | NM_206933.4 | ENSP00000305941.3 | ||
USH2A | ENST00000674083.1 | c.14191G>A | p.Gly4731Arg | missense_variant | 65/73 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151634Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251370Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135842
GnomAD4 exome AF: 0.000171 AC: 250AN: 1461886Hom.: 0 Cov.: 33 AF XY: 0.000183 AC XY: 133AN XY: 727246
GnomAD4 genome AF: 0.000112 AC: 17AN: 151748Hom.: 0 Cov.: 32 AF XY: 0.0000944 AC XY: 7AN XY: 74128
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 29, 2015 | The p.Gly4731Arg variant in USH2A has not been previously reported in individual s with hearing loss but has been identified in 5/66652 European chromosomes by t he Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1 48674752). Computational prediction tools and conservation analyses do not provi de strong support for or against an impact to the protein. In summary, the clin ical significance of the p.Gly4731Arg variant is uncertain. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2024 | The c.14191G>A (p.G4731R) alteration is located in exon 65 (coding exon 64) of the USH2A gene. This alteration results from a G to A substitution at nucleotide position 14191, causing the glycine (G) at amino acid position 4731 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Usher syndrome type 2A Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 17, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at